Compare PRLD & BTQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRLD | BTQ |
|---|---|---|
| Founded | 2016 | 1983 |
| Country | United States | Canada |
| Employees | N/A | 35 |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.1M | 517.7M |
| IPO Year | 2020 | N/A |
| Metric | PRLD | BTQ |
|---|---|---|
| Price | $3.79 | $2.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $9.20 | $7.93 |
| AVG Volume (30 Days) | 395.6K | ★ 2.0M |
| Earning Date | 11-11-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.21 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,140,000.00 | N/A |
| Revenue This Year | $258.83 | $763.72 |
| Revenue Next Year | N/A | $175.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 73.43 | N/A |
| 52 Week Low | $1.15 | $2.09 |
| 52 Week High | $6.83 | $16.00 |
| Indicator | PRLD | BTQ |
|---|---|---|
| Relative Strength Index (RSI) | 32.49 | 46.92 |
| Support Level | $3.40 | $2.59 |
| Resistance Level | $4.10 | $3.42 |
| Average True Range (ATR) | 0.28 | 0.15 |
| MACD | -0.08 | 0.05 |
| Stochastic Oscillator | 11.76 | 79.06 |
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.
BTQ Technologies Corp is engaged in the development of computer-based technology related to post-quantum cryptography, particularly as it applies to blockchain and related technologies, and their protection from the emerging security risk of quantum computing. The company derives revenue from Software licensing. Geographically, the company has a presence in Canada, Taiwan, Australia, and the United States.